News
An international consensus statement on generalized pustular psoriasis (GPP) from the International Psoriasis Council (IPC) includes the recommendation that considerations such as body surface ...
Generalized pustular psoriasis, or GPP, is a rare and severe form of the autoimmune disease psoriasis.A GPP flare involves a widespread rash accompanied by pustules — small bumps containing pus ...
Mark G. Lebwohl, MD, gives an overview of generalized pustular psoriasis (GPP) and explains how it differs from the more common plaque psoriasis.
The Food and Drug Administration (FDA) has expanded the approval of Spevigo ® (spesolimab-sbzo) to include the treatment of generalized pustular psoriasis (GPP) in adult and pediatric patients 12 ...
Generalized pustular psoriasis may be caused or triggered by various factors, including genetic mutations, infections, and certain medications. Generalized pustular psoriasis (GPP) is a severe ...
Stress, infections, and corticosteroid withdrawal are known triggers of generalized pustular psoriasis (GPP). However, doctors cannot attribute every GPP flare to a specific cause. Psoriasis is an ...
Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat generalised pustular psoriasis (GPP) flares.
Patients with generalized pustular psoriasis continued to experience frequent flares that were often uncontrolled by traditional off-label therapies, according to a study. Patients with ...
RIDGEFIELD, Conn., March 7, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim announced new analyses to be presented at the American Academy of Dermatology (AAD) annual meeting in Orlando that ...
Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48 weeks 1; Prevention of unpredictable flares addresses a high unmet patient need 2,3 ...
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This ...
Aaron Farberg, MD, and Mark G. Lebwohl, MD, discuss the common comorbidities seen in patients with generalized pustular psoriasis (GPP) and some potential future developments in the management of GPP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results